IP Library Granted Patent US 10,357,531
Granted Patent B2
US 10,357,531 · App. 15/032,179 · Granted Jul 23, 2019

Method for the management of cancer and cancer treatment-related comorbidities

Inventors: Saad Harti (Lutry, CH); JiaWei Liu (Geneva, CH)
Assignee: Legacy Healthcare Ltd.
A61K36/88A61K31/352A61K36/18A61K36/185A61K36/752A61K36/77A61K36/8962
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,357,531
App. No.
15/032,179
Granted
Jul 23, 2019
Kind
B2
Abstract

A method for the management of cancer and treatment of cancer comorbidities, including but not limited to cancer-related fatigue, cachexia, anorexia, pain, anemia, asthenia, depression, muscle weakness, nausea, vomiting, skin, and skin appendages adverse reactions; the method including the administration by the conventional and non-conventional oral, topical, parenteral routes and intra-tumoral injection, or in combination thereof, or the administration as adjuvant potentiator in other therapies using the forenamed routes, of a composition containing as active ingredient an extract of Allium species, which contains querceting, an extract of Citrus species and an extract of Paullinia species and an extract of Theobroma species.

Claims (6)

1. A method for management of cancer and for treatment of cancer-related fatigue in a subject in need thereof, the method comprising:

administering to the subject, by an oral route, a topical route, a parenteral route, an intra-tumoral injection, or a combination thereof, a composition comprising as an active ingredient an extract of Allium species comprising quercetin, an extract of Citrus species, an extract of Paullinia species and an extract of Theobroma species.

2. A method for the management of the cancer and for the treatment of cancer-related fatigue according to claim 1 , wherein the composition contains the extract of the Allium species comprising quercetin, the extract of the Citrus species, an atomized extract of the Paullinia species and an atomized extract of the Theobroma species.

3. A method for the management of the cancer and for the treatment cancer-related fatigue according to claim 1 , wherein the composition comprises: from 30% to 93% by weight of the extract of the Allium species comprising quercetin, from 3% to 33% by weight of the extract of the Citrus species, from 0.10% to 2.5% by weight of the extract of the Pauffinia species, and from 0.10% to 2.5% by weight of the extract of the Theobroma species, based on the total weight of the four active ingredients.

4. A method for management of cancer and for treatment of cancer-related fatigue in a subject in need thereof, the method comprising:

administering to the subject, by an oral route, a topical route, a parenteral route, an intra-tumoral injection, or a combination thereof, a composition consisting of an extract of Allium species comprising quercetin, an extract of Citrus species, an extract of Pauffinia species, and an extract of Theobroma species.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 19, 2020
From: LEGACY HEALTHCARE LTD
To: LEGACY HEALTHCARE (SWITZERLAND) SA
Reel/Frame 054413/0762 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2016
From: HARTI, SAAD; LIU, JIAWEI
To: LEGACY HEALTHCARE LTD.
Reel/Frame 038656/0119 →
Continuity (2)
Provisional Application 61901631 · Nov 8, 2013
Related Publication 20160256512A1 · Sep 8, 2016